5861 - 5870 of 6230 Results
Title
Year
- Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization2015OPENTitle: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and InternalizationJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 291Issue #: 9Start Page: 4374End Page: 4385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m115.705095Best OA location URL: http://www.jbc.org/article/S0021925820435859/pdfCitation Count: 145
- Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia2024OPENTitle: Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 10Start Page: 3547End Page: 3561Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae140Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae140/59000848/awae140.pdfCitation Count: 5
- The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease2012OPENTitle: The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 187End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.029Best OA location URL: https://europepmc.org/articles/pmc3432150?pdf=renderCitation Count: 30
-
OPENTitle: Metabolomics of sebum reveals lipid dysregulation in Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-21669-4Best OA location URL: https://www.nature.com/articles/s41467-021-21669-4.pdfCitation Count: 166
-
OPENTitle: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 179End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27223Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27223Citation Count: 35
- NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate2018OPENTitle: NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primateJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 96Issue #: 7Start Page: 1324End Page: 1335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.24230Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5980712Citation Count: 25
- M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder2019OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 33
- BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides2025OPENTitle: BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating TriglyceridesJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c03046Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c03046Citation Count: 4
- Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers2016OPENTitle: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1201End Page: 1211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00036Citation Count: 57
- A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra2020OPENTitle: A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigraJournal Name: Aging CellPublisher: WileyVol: 19Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13115Citation Count: 60